FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044762644> ?p ?o ?g. }

• W3044762644 endingPage "1349" @default.
• W3044762644 startingPage "1336" @default.
• W3044762644 abstract "Transforming growth factor beta (TGFβ) is a pleiotropic cytokine that plays a key role in both physiologic and pathologic conditions, including cancer. Importantly, TGFβ can exhibit both tumor-suppressive and oncogenic functions. In normal epithelial cells TGFβ acts as an antiproliferative and differentiating factor, whereas in advanced tumors TGFβ can act as an oncogenic factor by creating an immune-suppressive tumor microenvironment, and inducing cancer cell proliferation, angiogenesis, invasion, tumor progression, and metastatic spread. A wealth of preclinical findings have demonstrated that targeting TGFβ is a promising means of exerting antitumor activity. Based on this rationale, several classes of TGFβ inhibitors have been developed and tested in clinical trials, namely, monoclonal, neutralizing, and bifunctional antibodies; antisense oligonucleotides; TGFβ-related vaccines; and receptor kinase inhibitors. It is now >15 years since the first clinical trial testing an anti-TGFβ agent was engaged. Despite the promising preclinical studies, translation of the basic understanding of the TGFβ oncogenic response into the clinical setting has been slow and challenging. Here, we review the conclusions and status of all the completed and ongoing clinical trials that test compounds that inhibit the TGFβ pathway, and discuss the challenges that have arisen during their clinical development. With none of the TGFβ inhibitors evaluated in clinical trials approved for cancer therapy, clinical development for TGFβ blockade therapy is primarily oriented toward TGFβ inhibitor combinations. Immune checkpoint inhibitors are considered candidates, albeit with efficacy anticipated to be restricted to specific populations. In this context, we describe current efforts in the search for biomarkers for selecting the appropriate cancer patients who are likely to benefit from anti-TGFβ therapies. The knowledge accumulated during the last 15 years of clinical research in the context of the TGFβ pathway is crucial to design better, innovative, and more successful trials." @default.
• W3044762644 created "2020-07-29" @default.
• W3044762644 creator A5015509025 @default.
• W3044762644 creator A5016108968 @default.
• W3044762644 creator A5047539709 @default.
• W3044762644 creator A5064766886 @default.
• W3044762644 date "2020-10-01" @default.
• W3044762644 modified "2023-10-17" @default.
• W3044762644 title "Clinical development of therapies targeting TGFβ: current knowledge and future perspectives" @default.
• W3044762644 cites W1702502468 @default.
• W3044762644 cites W1934094702 @default.
• W3044762644 cites W1964297915 @default.
• W3044762644 cites W1966857167 @default.
• W3044762644 cites W1974423029 @default.
• W3044762644 cites W1975616120 @default.
• W3044762644 cites W1982734162 @default.
• W3044762644 cites W1998714482 @default.
• W3044762644 cites W1999132074 @default.
• W3044762644 cites W2000315116 @default.
• W3044762644 cites W2008869198 @default.
• W3044762644 cites W2027303624 @default.
• W3044762644 cites W2028919524 @default.
• W3044762644 cites W2029669343 @default.
• W3044762644 cites W2032347891 @default.
• W3044762644 cites W2035653659 @default.
• W3044762644 cites W2045626840 @default.
• W3044762644 cites W2045963664 @default.
• W3044762644 cites W2047475076 @default.
• W3044762644 cites W2058980003 @default.
• W3044762644 cites W2063076489 @default.
• W3044762644 cites W2064641323 @default.
• W3044762644 cites W2069414088 @default.
• W3044762644 cites W2069642304 @default.
• W3044762644 cites W2070539534 @default.
• W3044762644 cites W2074604431 @default.
• W3044762644 cites W2075497099 @default.
• W3044762644 cites W2075873658 @default.
• W3044762644 cites W2085114559 @default.
• W3044762644 cites W2085183887 @default.
• W3044762644 cites W2085963386 @default.
• W3044762644 cites W2086602355 @default.
• W3044762644 cites W2086692663 @default.
• W3044762644 cites W2087874061 @default.
• W3044762644 cites W2089612685 @default.
• W3044762644 cites W2092513068 @default.
• W3044762644 cites W2095605427 @default.
• W3044762644 cites W2096287682 @default.
• W3044762644 cites W2097096499 @default.
• W3044762644 cites W2099361912 @default.
• W3044762644 cites W2100801124 @default.
• W3044762644 cites W2100825082 @default.
• W3044762644 cites W2101813432 @default.
• W3044762644 cites W2102298863 @default.
• W3044762644 cites W2107780185 @default.
• W3044762644 cites W2110994430 @default.
• W3044762644 cites W2111063080 @default.
• W3044762644 cites W2116583846 @default.
• W3044762644 cites W2117225762 @default.
• W3044762644 cites W2119584041 @default.
• W3044762644 cites W2121126525 @default.
• W3044762644 cites W2126821510 @default.
• W3044762644 cites W2130643308 @default.
• W3044762644 cites W2132734173 @default.
• W3044762644 cites W2136280424 @default.
• W3044762644 cites W2140740750 @default.
• W3044762644 cites W2142957616 @default.
• W3044762644 cites W2150548551 @default.
• W3044762644 cites W2152049148 @default.
• W3044762644 cites W2154568166 @default.
• W3044762644 cites W2157662622 @default.
• W3044762644 cites W2161186807 @default.
• W3044762644 cites W2164672043 @default.
• W3044762644 cites W2169237074 @default.
• W3044762644 cites W2247505779 @default.
• W3044762644 cites W2344628383 @default.
• W3044762644 cites W2344682920 @default.
• W3044762644 cites W2347012456 @default.
• W3044762644 cites W2462071496 @default.
• W3044762644 cites W2481611869 @default.
• W3044762644 cites W2491676082 @default.
• W3044762644 cites W2527905628 @default.
• W3044762644 cites W2551025035 @default.
• W3044762644 cites W2554580968 @default.
• W3044762644 cites W2570763587 @default.
• W3044762644 cites W2592102847 @default.
• W3044762644 cites W2592339836 @default.
• W3044762644 cites W2593598026 @default.
• W3044762644 cites W2604233803 @default.
• W3044762644 cites W2608573151 @default.
• W3044762644 cites W2781947653 @default.
• W3044762644 cites W2783370150 @default.
• W3044762644 cites W2785803176 @default.
• W3044762644 cites W2788975052 @default.
• W3044762644 cites W2789720205 @default.
• W3044762644 cites W2792793299 @default.
• W3044762644 cites W2794847062 @default.
• W3044762644 cites W2856466152 @default.
• W3044762644 cites W2895806415 @default.

• next